/Companies

Antarka

7 known investors

Find your way into Antarka

Sign up to see every warm intro you have to Antarka

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Antarka team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Antarka develops a skin-permeable enzyme derived from Antarctic organisms that repairs UV-induced DNA damage, offered as a high-purity active ingredient for cosmetic brands to formulate into anti-aging creams, sunscreens, and repair serums. The company operates in the biotech and dermocosmetics space, supplying formulators rather than selling finished consumer products directly.

Founders & leadership

BMBetania Martínez
Betania MartínezCo-founder & CTOFounder of Antarka, with a research background in photobiology focused on Antarctic photolyases. The company develops a skin-permeable enzyme derived from Antarctic organisms that repairs UV-induced DNA damage, supplied as an active ingredient to cosmetic formulators.
JJ
Juan Jose MarizcurrenaCSO & Co-founder
CCCelica Cagide
Celica CagideCo-Founder & COOCOO & Co-founder, Antarka

Investors · 7

Frequently asked questions

What does Antarka do?
Antarka develops a skin-permeable enzyme derived from Antarctic organisms that repairs UV-induced DNA damage, offered as a high-purity active ingredient for cosmetic brands to formulate into anti-aging creams, sunscreens, and repair serums. The company operates in the biotech and dermocosmetics space, supplying formulators rather than selling finished consumer products directly.
Who founded Antarka?
Antarka was founded by Betania Martínez, Juan Jose Marizcurrena, Celica Cagide.
Who are Antarka's investors?
Antarka's investors include AIR Capital, GRIDX, GS Futures, SOSV, Vox Capital, Zentynel Frontier Investments, IndieBio.